Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Prev Med. 2016 Apr 17;92:51–57. doi: 10.1016/j.ypmed.2016.04.013

Table 1.

Participant baseline characteristics (Providence, RI, 2013–2014).

Total (N=75) CB Pro (N=25) CB Peer (N=26) Standard (N=24) p-value
Female, n (%) 64 (85.3) 22 (88.0) 22 (84.6) 20 (83.3) 0.89

Age, mean (SD) 48.5 (10.7) 47.6 (11.9) 46.9 (11.6) 51.1 (8.2) 0.34

Race, n (%) 0.36
 White 66 (88.0) 21 (84.0) 22 (84.6) 23 (95.8)
 Non-White 9 (12.0) 4 (16.0) 4 (15.4) 1 (4.2)

Ethnicity, n (%) 0.42
 Not Hispanic/Latino 73 (97.3) 24 (96.0) 25 (96.2) 24 (100.0)
 Hispanic/Latino 1 (1.3) 0 (0.0) 1 (1.3) 0 (0.0)
 Declined to answer 1 (1.3) 1 (1.3) 0 (0.0) 0 (0.0)

Education 0.20
 High School (10–12yr) 3 (4.0) 1 (4.0) 2 (7.7) 0 (0.0)
 Vocational (> HS) 4 (5.3) 0 (0.0) 1 (3.8) 3 (12.5)
 Some college (<4yr) 13 (17.3) 8 (32.0) 2 (7.7) 3 (12.5)
 College/Univ Grad 29 (38.7) 8 (32.0) 11 (42.3) 10 (41.7)
 Grad/Prof School 26 (34.7) 8 (32.0) 10 (38.5) 8 (33.3)

Income 0.10
 0–$25,000 2 (2.7) 0 (0.0) 0 (0.0) 2 (8.3)
 $25,001–$50,000 10 (13.3) 6 (24.0) 2 (7.7) 2 (8.3)
 $50,001–$75,000 15 (20.0) 5 (20.0) 3 (11.5) 7 (29.2)
 $75,001–$100,000 14 (18.7) 5 (20.0) 8 (30.8) 1 (4.2)
 $100,001–$125,000 16 (21.3) 3 (12.0) 6 (23.1) 7 (29.2)
 $125,000+ 18 (24.0) 6 (24.0) 7 (26.9) 5 (20.8)

Phase I % wt Loss (SD) 8.0 (2.1) 7.9 (1.9) 8.3 (2.3) 7.8 (2.1) 0.59

Phase I kg wt loss (SD) −7.2 (2.1) −7.3 (1.9) −7.6 (2.4) −6.7 (1.6) 0.23

Phase II baseline BMI, mean (SD) 31.5 (5.8) 31.6 (5.9) 30.6 (5.0) 29.4 (4.3) 0.33

Phase II baseline weight kg, mean (SD) 85.7 (19.5) 88.8 (20.9) 85.8 (19.2) 77.5 (15.3) 0.10